CELG Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: CELG Shares Outstanding History and CELG YTD Return |
CELG Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: CELG Shares Outstanding History and CELG YTD Return |
CELG Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+11.50% CAGR Mouse over chart for data details
|
CELG Stock Price Chart |
About Bristol Myers Squibb Co. |
Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s pharmaceutical products include chemically-synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor T-cell therapies. Co.'s primary product includes Eliquis® - Eliquis (apixaban), which is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy. We show 41 historical shares outstanding datapoints in our CELG shares outstanding history coverage, used to compute CELG market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing Celgene market cap history over the course of time is important for investors interested in comparing Celgene's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of Celgene versus a peer is one thing; comparing Celgene market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like Celgene can fluctuate over the course of history. With this page we aim to empower investors researching Celgene by allowing them to research the Celgene market cap history. |
CELG Current Stock Quote |
Free CELG Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
CELG Share Performance |
Market Cap Peers |
Celgene (CELG) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CELL Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.